Expression of SREBF2 and HMGCR discriminates the viability of steatotic grafts for human liver transplantation
Journal of Lipid Research · 2025
DOI: 10.1016/j.jlr.2025.100901 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2025. Verfasst von Anna Baulies und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Death and Proliferation, Institute of Biomedical Research of Barcelona (IIBB-CSIC), Unidad Asociada IMIM/IIBB-CSIC, Barcelona, Spa…. Hauptthemen laut MEDLINE: Liver Transplantation, Fatty Liver, Hydroxymethylglutaryl CoA Reductases, Sterol Regulatory Element Binding Protein 2. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Plan for Scientific and Technical Research and Innovation, Fundación Mutua Madrileña, Generalitat de Catalunya.
Abstract (Originalsprache)
Hepatic steatosis presents a rising challenge in liver transplantation (LT), yet the precise underlying players remain incompletely understood. As steatosis reflects the accumulation of several types of lipids, including cholesterol, which has emerged as a key player in metabolic-dysfunction associated fatty liver disease, we aimed to characterize the content of lipids and the expression of cholesterol metabolic genes in liver biopsies before (pre-LT) and after LT (post-LT), with the ultimate goal of identifying factors that may impact graft loss and the overall outcomes of LT. Lipid content and cholesterol-related genes in pre- and post-LT graft biopsies, clinical outcome, and survival within the first year after LT were analyzed in 174 patients. Unlike free fatty acids (FFA) and triglycerides, total and free cholesterol (FC) levels are maintained in pre- and post-LT samples. Increased FC and FFA levels in pre-LT samples were associated with early allograft dysfunction (EAD). The increase in the expression of cholesterol regulatory genes SREBF2 and HMGCR in pre-LT samples was identified as a potential risk factor of death after LT, particularly with SREBF2, whose expression is associated with EAD and graft loss (GL). Collectively, these data link the expression of genes involved in the synthesis of cholesterol to LT-related mortality. These findings may translate to an increased application of marginal steatotic grafts in LT, thereby promoting a safe outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Death and Proliferation, Institute of Biomedical Research of Barcelona (IIBB-CSIC), Unidad Asociada IMIM/IIBB-CSIC, Barcelona, Spain; Liver Unit, Instituto de Investigaciones Biomédicas August Pi i Su…
- Biostatistics and Data Management Core Facility, Faculty of Medicine, IDIBAPS, Hospital Clínic Barcelona, Biostatistics Unit, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Liver Unit, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Hospital Clinic I Provincial de Barcelona, Barcelona, Spain; Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carl…
- CORE Laboratory, Biochemistry and Molecular Genetics Department, Biomedical Diagnostic Centre, Hospital Clínic, Barcelona, Spain.
- Barcelona Clinic Liver Cancer (BCLC) group, Liver Oncology Unit, Surgery Department, Hospital Clinic de Barcelona, Barcelona, Spain; School of Medicine, Barcelona University, Barcelona, Spain.
- School of Medicine, Barcelona University, Barcelona, Spain; Donation and Transplant Coordination Section, Hospital Clinic de Barcelona, Barcelona, Spain.
Förderung
- National Plan for Scientific and Technical Research and Innovation
- Fundación Mutua Madrileña
- Generalitat de Catalunya
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- European Regional Development Fund
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- National Institutes of Health
- Agencia Estatal de Investigación
Zitieren
APA
Baulies, A., Torres, S., Fucho, R., Núñez, S., Torres, F., Ferrer-Fàbrega, J., Díaz, A., Rico, N., García-Valdecasas, J. C., Fuster, J., Adalia, R., Paredes, D., Rimola, A., Fernández-Checa, J. C., & García-Ruiz, C. (2025). Expression of SREBF2 and HMGCR discriminates the viability of steatotic grafts for human liver transplantation. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2025.100901
Vancouver
Baulies A, Torres S, Fucho R, Núñez S, Torres F, Ferrer-Fàbrega J, et al. Expression of SREBF2 and HMGCR discriminates the viability of steatotic grafts for human liver transplantation. Journal of Lipid Research. 2025. doi:10.1016/j.jlr.2025.100901
BibTeX
@article{Baulies2025,
author = {Baulies, Anna and Torres, Sandra and Fucho, Raquel and Núñez, Susana and Torres, Ferran and Ferrer-Fàbrega, Joana and Díaz, Alba and Rico, Naira and García-Valdecasas, Juan Carlos and Fuster, Josep and Adalia, Ramon and Paredes, David and Rimola, Antoni and Fernández-Checa, José C and García-Ruiz, Carmen},
title = {Expression of SREBF2 and HMGCR discriminates the viability of steatotic grafts for human liver transplantation},
journal = {Journal of Lipid Research},
year = {2025},
doi = {10.1016/j.jlr.2025.100901}
}
EUVIMED